Intramuscular and intravenous levetiracetam in humans: Safety and pharmacokinetics

Epilepsy Research

Volumn 91, Issue 2-3, 2010, Pages 289-292

  Leppik, Ilo E ^a,b   Goel, Varun ^a   Rarick, John ^a   Nixdorf, Donald R ^a   Cloyd, James C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MINCEP Epilepsy Care   (United States)

Author keywords

Half life; Intramuscular; Intravenous; Levetiracetam; Pharmacokinetics

Indexed keywords

ETIRACETAM;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; CROSS-OVER STUDIES; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PIRACETAM; YOUNG ADULT;

EID: 77957020271     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.07.016     Document Type: Article

References (5)

1. Gould D., Kelly D., Goldstone L., Gammon J. Examining the validity of pressure ulcer risk assessment scales: developing and using illustrated patient simulations to collect the data: Visual Analogue Scale. J. Clin. Nurs. 2001, 10:697-706.
2. Leppik I.E. The place of levetiracetam in the treatment of epilepsy. Epilepsia 2004, 42(Suppl. 4):44-45.
3. Lynch B., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagn A., Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. PNAS 2004, 101:9861-9866.
4. Patterson E.E., Goel V., O'Brien T.D., Fisher J.E., Dunn A.W., Leppik I.E. Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics. J. Vet. Pharmacol. Ther. 2008, 31:253-258.
5. Ramael S., De Smedt F., Toublanc N., Otoul E.C., Boulanger P., Riethuisen J., Stockis A. Single-dose bioavailability of leviteracetam intravenous infusion relative to oral tablets and multiple dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin. Ther. 2006, 28:734-744.